Judith Guenther

This inventor holds 6 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Bayer Schering Pharma Ag, Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judith Guenther. Retrieved from https://idiyas.com/inventor/judith-guenther

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 15(Granted Patents)

Company Filing History:

3 out of 192

Bayer Schering Pharma Ag

patents

2 out of 387

Bayer Pharma Aktiengesellschaft

patents

1 out of 721

Bayer Intellectual Property Gmbh

patents

Years Active: 2009-2014

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8653076 - Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals (2014-02-18),

2. 8163739 - 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals (2012-04-24),

3. 8148411 - 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals (2012-04-03),

4. 7897626 - 2-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals (2011-03-01),

5. 7741333 - Quinazoline derivatives, their preparation, their use, and medicaments comprising them (2010-06-22),

6. 7598263 - Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them (2009-10-06),

Title: Inventor Spotlight: Judith Guenther Revolutionizing Pharmaceuticals in Berlin

Introduction:

Judith Guenther, a brilliant inventor hailing from Berlin, Germany, has made significant contributions to the field of pharmaceuticals with her innovative patents and discoveries.

Latest Patents:

Judith Guenther holds 6 patents, with her latest groundbreaking inventions revolving around Oxo-substituted imidazo[1,2B]pyridazines as pharmaceuticals and 2-arylthiazole-4-carboxamide derivatives for medicinal treatments. These patents showcase her deep understanding of molecular structures and their applications in the medical industry.

Career Highlights:

Having worked at esteemed pharmaceutical companies like Bayer Schering Pharma AG and Bayer Pharma Aktiengesellschaft, Judith Guenther has honed her skills and expertise in drug development and research. Her journey in the pharmaceutical sector has been marked by notable achievements and significant breakthroughs.

Collaborations:

Throughout her career, Judith Guenther has collaborated with esteemed professionals in the field, including Arne Von Bonin and Ulrich Bothe. Together, they have synergized their knowledge and skills to facilitate the development of novel pharmaceutical compounds and treatments.

Conclusion:

In conclusion, Judith Guenther stands as a pioneering figure in the pharmaceutical industry, with her inventive spirit and dedication to advancing healthcare through innovative patents. Her contributions have undoubtedly shaped the landscape of modern medicine, making her a revered inventor in Berlin and beyond.

Profile summary based on public USPTO records.